HY-42490-100mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-42490-50mg
|
MedChemexpress LLC
|
N3-PEG3-CH2CH2COOH [CAS 1056024-94-2]
|
|
COVID-19-immunoregulation
|
|
HY-17639-1mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-10mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-25mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-17639-5mg
|
MedChemexpress LLC
|
Navamepent [CAS 1251537-11-7]
|
|
COVID-19-immunoregulation
|
|
HY-153785-1mg
|
MedChemexpress LLC
|
NH2-C6-ARC186 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-153785-10mg
|
MedChemexpress LLC
|
NH2-C6-ARC186 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-153785-5mg
|
MedChemexpress LLC
|
NH2-C6-ARC186 (sodium)
|
|
COVID-19-immunoregulation
|
|
HY-112433-10mg
|
MedChemexpress LLC
|
NIK SMI1 [CAS 1660114-31-7]
|
|
COVID-19-immunoregulation
|
|
HY-112433-100mg
|
MedChemexpress LLC
|
NIK SMI1 [CAS 1660114-31-7]
|
|
COVID-19-immunoregulation
|
|
HY-112433-5mg
|
MedChemexpress LLC
|
NIK SMI1 [CAS 1660114-31-7]
|
|
COVID-19-immunoregulation
|
|
HY-112433-50mg
|
MedChemexpress LLC
|
NIK SMI1 [CAS 1660114-31-7]
|
|
COVID-19-immunoregulation
|
|
HY-112433-1mL
|
MedChemexpress LLC
|
NIK SMI1 [CAS 1660114-31-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-B1710-100mg
|
MedChemexpress LLC
|
Norethindrone acetate [CAS 51-98-9]
|
|
COVID-19-immunoregulation
|
|
HY-B1710-500mg
|
MedChemexpress LLC
|
Norethindrone acetate [CAS 51-98-9]
|
|
COVID-19-immunoregulation
|
|
HY-B1710-1mL
|
MedChemexpress LLC
|
Norethindrone acetate [CAS 51-98-9] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
HY-126250-10mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-126250-100mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-126250-25mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-126250-5mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-126250-50mg
|
MedChemexpress LLC
|
NPD-1335 [CAS 2376326-31-5]
|
|
COVID-19-immunoregulation
|
|
HY-145942-25g
|
MedChemexpress LLC
|
Octenyl succinic anhydride [CAS 26680-54-6]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-1mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|
HY-P99791-10mg
|
MedChemexpress LLC
|
Orilanolimab [CAS 2066544-85-0]
|
|
COVID-19-immunoregulation
|
|